Enliven Therapeutics Inc.

NASDAQ: ELVN · Real-Time Price · USD
21.63
-0.66 (-2.96%)
At close: Jun 05, 2025, 1:40 PM
-2.96%
Bid 21.38
Market Cap 1.06B
Revenue (ttm) n/a
Net Income (ttm) -94.83M
EPS (ttm) -1.92
PE Ratio (ttm) -11.27
Forward PE -7.81
Analyst Buy
Ask 21.88
Volume 302,143
Avg. Volume (20D) 328,842
Open 22.00
Previous Close 22.29
Day's Range 21.43 - 22.60
52-Week Range 13.30 - 30.03
Beta 0.95

About ELVN

undefined

Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ELVN
Website n/a
Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for ELVN stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts
2 weeks ago
-10.41%
Enliven Therapeutics shares are trading lower afte... Unlock content with Pro Subscription
8 months ago
+6.02%
Enliven Therapeutics shares are trading higher after the company provided more details regarding the presentation of its updated ELVN-001 Phase1a data of ESH-iCML at the 26th annual John Goldman Conference on CML.